Austar Lifesciences Limited Provided Group Earnings Guidance for the six months ending 30 June 2023. For the period, the group recorded a net loss of approximately RMB 22 million for the five months ended 31 May 2023 and is expected to record a loss attributable to the owners of the Company as compared with a profit attributable to the owners of the Company of approximately RMB 45.8 million for the six months ended 30 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 HKD | -3.95% | -23.16% | -53.21% |
Mar. 26 | Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 22 | Austar Lifesciences to Swing to Loss; Shares Drop | MT |
1st Jan change | Capi. | |
---|---|---|
-53.21% | 49.84M | |
-3.78% | 184B | |
-1.12% | 107B | |
-2.41% | 69.44B | |
+2.85% | 50.37B | |
+8.90% | 44.82B | |
+3.40% | 41.53B | |
+3.69% | 26.84B | |
+3.85% | 26.73B | |
+15.23% | 25.71B |
- Stock Market
- Equities
- 6118 Stock
- News Austar Lifesciences Limited
- Austar Lifesciences Limited Provides Group Earnings Guidance for the Six Months Ending 30 June 2023